Drug Type Small molecule drug |
Synonyms- |
Mechanism MEK1 inhibitors(Dual specificity mitogen-activated protein kinase kinase 1 inhibitors), MEK2 inhibitors(Dual specificity mitogen-activated protein kinase kinase 2 inhibitors), PI3Kα inhibitors(Phosphatidylinositol 3 kinase alpha inhibitors) + [2] |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Molecular FormulaC15H16ClFIN3O3 |
InChIKeyHIEXZUXKTABHCP-PPHPATTJSA-N |
CAS Registry1236361-78-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Cancer | Phase 2 | - | - | |
Ovarian Cancer | Phase 2 | - | - | |
Solid tumor | Phase 2 | - | - |